Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT07221253

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

Led by AstraZeneca · Updated on 2026-03-17

1100

Participants Needed

168

Research Sites

186 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to measure the efficacy and safety of rilvegostomig with gemcitabine plus cisplatin vs. durvalumab with gemcitabine plus cisplatin as first line treatment for patients with advanced BTC.

CONDITIONS

Official Title

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically confirmed adenocarcinoma of the biliary tract, including intra-hepatic or extra-hepatic cholangiocarcinoma and gallbladder carcinoma
  • Unresectable locally advanced or metastatic biliary tract cancer, untreated in the advanced setting
  • Known PD-L1 status assessed centrally using an acceptable tumor sample
  • Measurable disease by RECIST 1.1 criteria using CT or MRI suitable for repeated measurements
  • ECOG Performance Status of 0 or 1 with no deterioration over the previous 2 weeks before screening and randomization
  • Adequate bone marrow and organ function
Not Eligible

You will not qualify if you...

  • Ampullary carcinoma
  • Prior systemic therapy for unresectable, locally advanced or metastatic biliary tract cancer
  • Prior exposure to therapies targeting immune-regulatory receptors or mechanisms
  • Concurrent chemotherapy, radiotherapy, immunotherapy, investigational, biologic, or hormonal cancer treatments other than study interventions
  • Active or prior autoimmune or inflammatory disorders requiring chronic steroids or immunosuppressive treatment
  • Active or ongoing interstitial lung disease or pneumonitis of any grade
  • Serious chronic gastrointestinal conditions with diarrhea
  • Active non-infectious skin diseases requiring systemic treatment such as rash, urticaria, dermatitis, ulceration, or psoriasis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 168 locations

1

Research Site

Birmingham, Alabama, United States, 35233

Not Yet Recruiting

2

Research Site

Phoenix, Arizona, United States, 85054

Not Yet Recruiting

3

Research Site

Tucson, Arizona, United States, 85719

Not Yet Recruiting

4

Research Site

Duarte, California, United States, 91010

Actively Recruiting

5

Research Site

Orange, California, United States, 92868

Not Yet Recruiting

6

Research Site

Santa Monica, California, United States, 90404

Not Yet Recruiting

7

Research Site

Stanford, California, United States, 94305-5847

Not Yet Recruiting

8

Research Site

Aurora, Colorado, United States, 80045

Not Yet Recruiting

9

Research Site

Hartford, Connecticut, United States, 06102

Not Yet Recruiting

10

Research Site

New Haven, Connecticut, United States, 06510

Not Yet Recruiting

11

Research Site

Washington D.C., District of Columbia, United States, 20007

Not Yet Recruiting

12

Research Site

Washington D.C., District of Columbia, United States, 20037

Not Yet Recruiting

13

Research Site

Jacksonville, Florida, United States, 32209

Not Yet Recruiting

14

Research Site

Jacksonville, Florida, United States, 32224

Not Yet Recruiting

15

Research Site

Marietta, Georgia, United States, 30060

Actively Recruiting

16

Research Site

Chicago, Illinois, United States, 60612

Not Yet Recruiting

17

Research Site

Chicago, Illinois, United States, 60637

Not Yet Recruiting

18

Research Site

Louisville, Kentucky, United States, 40207

Not Yet Recruiting

19

Research Site

Baltimore, Maryland, United States, 21205

Not Yet Recruiting

20

Research Site

Ann Arbor, Michigan, United States, 48109

Not Yet Recruiting

21

Research Site

Detroit, Michigan, United States, 48202

Not Yet Recruiting

22

Research Site

Rochester, Minnesota, United States, 55905

Not Yet Recruiting

23

Research Site

Omaha, Nebraska, United States, 68198-5885

Not Yet Recruiting

24

Research Site

Santa Fe, New Mexico, United States, 87505

Actively Recruiting

25

Research Site

New York, New York, United States, 10016

Not Yet Recruiting

26

Research Site

New York, New York, United States, 10032

Not Yet Recruiting

27

Research Site

New York, New York, United States, 10065

Withdrawn

28

Research Site

Portland, Oregon, United States, 97239

Not Yet Recruiting

29

Research Site

Philadelphia, Pennsylvania, United States, 19104

Not Yet Recruiting

30

Research Site

Philadelphia, Pennsylvania, United States, 19111

Not Yet Recruiting

31

Research Site

Pittsburgh, Pennsylvania, United States, 15212

Not Yet Recruiting

32

Research Site

Providence, Rhode Island, United States, 02903

Not Yet Recruiting

33

Research Site

Sioux Falls, South Dakota, United States, 57105

Actively Recruiting

34

Research Site

Darlinghurst, Australia, 2010

Actively Recruiting

35

Research Site

Gosford, Australia, 2250

Not Yet Recruiting

36

Research Site

Murdoch, Australia, 6150

Not Yet Recruiting

37

Research Site

Anderlecht, Belgium, 1070

Not Yet Recruiting

38

Research Site

Edegem, Belgium, 2650

Not Yet Recruiting

39

Research Site

Leuven, Belgium, 3000

Not Yet Recruiting

40

Research Site

Liège, Belgium, 4000

Not Yet Recruiting

41

Research Site

Roeselare, Belgium, 8800

Not Yet Recruiting

42

Research Site

Barretos, Brazil, 14784-400

Actively Recruiting

43

Research Site

Natal, Brazil, 59075-740

Actively Recruiting

44

Research Site

Porto Alegre, Brazil, 91350-200

Actively Recruiting

45

Research Site

Ribeirão Preto, Brazil, 14026-040

Not Yet Recruiting

46

Research Site

São Paulo, Brazil, 01246-000

Actively Recruiting

47

Research Site

Vitória, Brazil, 29043-272

Actively Recruiting

48

Research Site

Calgary, Alberta, Canada, T2N 5G2

Not Yet Recruiting

49

Research Site

Vancouver, British Columbia, Canada, VSZ 4E6

Not Yet Recruiting

50

Research Site

Halifax, Nova Scotia, Canada, B3H 2Y9

Actively Recruiting

51

Research Site

Barrie, Ontario, Canada, L4M 6M2

Not Yet Recruiting

52

Research Site

Toronto, Ontario, Canada, M4N 3M5

Actively Recruiting

53

Research Site

Toronto, Ontario, Canada, M5G 2M9

Actively Recruiting

54

Research Site

Montreal, Quebec, Canada, H4A 3J1

Not Yet Recruiting

55

Research Site

Québec, Quebec, Canada, G1J 1Z4

Not Yet Recruiting

56

Research Site

Beijing, China, 100020

Not Yet Recruiting

57

Research Site

Beijing, China, 102218

Not Yet Recruiting

58

Research Site

Changchun, China, 130021

Not Yet Recruiting

59

Research Site

Changde, China, 415000

Actively Recruiting

60

Research Site

Changsha, China, 410005

Not Yet Recruiting

61

Research Site

Changsha, China, 410013

Suspended

62

Research Site

Chengdu, China, 610078

Not Yet Recruiting

63

Research Site

Fuzhou, China, 350005

Actively Recruiting

64

Research Site

Guangzhou, China, 510515

Not Yet Recruiting

65

Research Site

Hangzhou, China, 310022

Not Yet Recruiting

66

Research Site

Hefei, China, 230001

Actively Recruiting

67

Research Site

Lishui, China, 323000

Withdrawn

68

Research Site

Luoyang, China, 471023

Not Yet Recruiting

69

Research Site

Nanchang, China, 330000

Not Yet Recruiting

70

Research Site

Nanning, China, 530000

Not Yet Recruiting

71

Research Site

Shandong, China

Not Yet Recruiting

72

Research Site

Shanghai, China, 200032

Not Yet Recruiting

73

Research Site

Shenyang, China, 110016

Not Yet Recruiting

74

Research Site

Weifang, China, 261000

Not Yet Recruiting

75

Research Site

Wuhan, China, 430030

Not Yet Recruiting

76

Research Site

Xi'an, China, 710061

Not Yet Recruiting

77

Research Site

Clichy, France, 92118

Not Yet Recruiting

78

Research Site

Grenoble, France, 38043

Not Yet Recruiting

79

Research Site

Marseille, France, 13385

Not Yet Recruiting

80

Research Site

Vandœuvre-lès-Nancy, France, 54511

Not Yet Recruiting

81

Research Site

Aachen, Germany, 52074

Not Yet Recruiting

82

Research Site

Berlin, Germany, 10365

Not Yet Recruiting

83

Research Site

Berlin, Germany, 13353

Not Yet Recruiting

84

Research Site

Bonn, Germany, 53127

Not Yet Recruiting

85

Research Site

Düsseldorf, Germany, 40225

Not Yet Recruiting

86

Research Site

Essen, Germany, 45122

Not Yet Recruiting

87

Research Site

Frankfurt, Germany, 60488

Not Yet Recruiting

88

Research Site

Freiburg im Breisgau, Germany, 79106

Not Yet Recruiting

89

Research Site

Hamburg, Germany, 20249

Not Yet Recruiting

90

Research Site

Hamburg, Germany, 22763

Not Yet Recruiting

91

Research Site

Heidelberg, Germany, 69120

Not Yet Recruiting

92

Research Site

Heilbronn, Germany, 74078

Not Yet Recruiting

93

Research Site

Karlsruhe, Germany, 76133

Not Yet Recruiting

94

Research Site

Magdeburg, Germany, 39120

Not Yet Recruiting

95

Research Site

München, Germany, 81737

Not Yet Recruiting

96

Research Site

Ulm, Germany, 89081

Not Yet Recruiting

97

Research Site

Delhi, India, 110029

Not Yet Recruiting

98

Research Site

Hyderabad, India, 500032

Not Yet Recruiting

99

Research Site

Kolhāpur, India, 416234

Not Yet Recruiting

100

Research Site

Kolkata, India, 700063

Not Yet Recruiting

101

Research Site

Mumbai, India, 400012

Not Yet Recruiting

102

Research Site

Nashik, India, 422002

Not Yet Recruiting

103

Research Site

Surat, India, 395002

Not Yet Recruiting

104

Research Site

Castellana Grotte, Italy, 70013

Not Yet Recruiting

105

Research Site

Milan, Italy, 20132

Not Yet Recruiting

106

Research Site

Pisa, Italy, 56126

Not Yet Recruiting

107

Research Site

Rome, Italy, 00168

Not Yet Recruiting

108

Research Site

Rozzano, Italy, 20089

Not Yet Recruiting

109

Research Site

Chiba, Japan, 260-8717

Actively Recruiting

110

Research Site

Kashiwa, Japan, 227-8577

Not Yet Recruiting

111

Research Site

Kawasaki-shi, Japan, 216-8511

Not Yet Recruiting

112

Research Site

Kōtoku, Japan, 135-8550

Actively Recruiting

113

Research Site

Matsuyama, Japan, 790-0024

Actively Recruiting

114

Research Site

Nagoya, Japan, 464-8681

Not Yet Recruiting

115

Research Site

Nagoya, Japan, 466-8560

Not Yet Recruiting

116

Research Site

Osaka, Japan, 541-8567

Not Yet Recruiting

117

Research Site

Suita-shi, Japan, 565-0871

Actively Recruiting

118

Research Site

Takatsuki-shi, Japan, 569-8686

Actively Recruiting

119

Research Site

Ube, Japan, 755-8505

Actively Recruiting

120

Research Site

Yokohama, Japan, 241-8515

Actively Recruiting

121

Research Site

Amsterdam, Netherlands, 1081 HV

Not Yet Recruiting

122

Research Site

Groningen, Netherlands, 9713 GZ

Not Yet Recruiting

123

Research Site

Maastricht, Netherlands, 6202 AZ

Not Yet Recruiting

124

Research Site

Utrecht, Netherlands, 3584 CX

Not Yet Recruiting

125

Research Site

Koszalin, Poland, 75-581

Not Yet Recruiting

126

Research Site

Krakow, Poland, 30-688

Not Yet Recruiting

127

Research Site

Lodz, Poland, 92-213

Not Yet Recruiting

128

Research Site

Olsztyn, Poland, 10-228

Not Yet Recruiting

129

Research Site

Warsaw, Poland, 02-034

Not Yet Recruiting

130

Research Site

Busan, South Korea, 48108

Actively Recruiting

131

Research Site

Daegu, South Korea, 41404

Not Yet Recruiting

132

Research Site

Seongnam-si, South Korea, 13496

Not Yet Recruiting

133

Research Site

Seongnam-si, South Korea, 13620

Actively Recruiting

134

Research Site

Seoul, South Korea, 03080

Actively Recruiting

135

Research Site

Seoul, South Korea, 03722

Not Yet Recruiting

136

Research Site

Seoul, South Korea, 05505

Actively Recruiting

137

Research Site

Seoul, South Korea, 06351

Actively Recruiting

138

Research Site

Seoul, South Korea, 06591

Not Yet Recruiting

139

Research Site

Barcelona, Spain, 08036

Not Yet Recruiting

140

Research Site

L'Hospitalet de Llobregat, Spain, 08908

Not Yet Recruiting

141

Research Site

Madrid, Spain, 28007

Not Yet Recruiting

142

Research Site

Madrid, Spain, 28040

Not Yet Recruiting

143

Research Site

Santander, Spain, 39008

Not Yet Recruiting

144

Research Site

Kaohsiung City, Taiwan, 82445

Actively Recruiting

145

Research Site

Kaohsiung City, Taiwan, 833

Actively Recruiting

146

Research Site

Taichung, Taiwan, 40447

Actively Recruiting

147

Research Site

Taichung, Taiwan, 40705

Actively Recruiting

148

Research Site

Tainan, Taiwan, 704

Actively Recruiting

149

Research Site

Taipei, Taiwan, 10002

Actively Recruiting

150

Research Site

Taipei, Taiwan, 112

Actively Recruiting

151

Research Site

Taoyuan, Taiwan, 333

Actively Recruiting

152

Research Site

Bangkok, Thailand, 10700

Not Yet Recruiting

153

Research Site

Chiang Mai, Thailand, 50200

Actively Recruiting

154

Research Site

Hat Yai, Thailand, 90110

Not Yet Recruiting

155

Research Site

Khon Kaen, Thailand, 40002

Actively Recruiting

156

Research Site

Muang, Thailand, 34000

Not Yet Recruiting

157

Research Site

Ongkharak, Thailand, 26120

Not Yet Recruiting

158

Research Site

Ankara, Turkey (Türkiye), 06100

Not Yet Recruiting

159

Research Site

Erzurum, Turkey (Türkiye), 25240

Not Yet Recruiting

160

Research Site

Istanbul, Turkey (Türkiye), 34010

Not Yet Recruiting

161

Research Site

Konya, Turkey (Türkiye), 42080

Not Yet Recruiting

162

Research Site

Seyhan, Turkey (Türkiye), 1060

Not Yet Recruiting

163

Research Site

Birmingham, United Kingdom, B15 2GW

Not Yet Recruiting

164

Research Site

Glasgow, United Kingdom, G12 OYN

Not Yet Recruiting

165

Research Site

Greater London, United Kingdom, SW3 6JJ

Not Yet Recruiting

166

Research Site

Leeds, United Kingdom, LS9 7TF

Not Yet Recruiting

167

Research Site

London, United Kingdom, NW3 2QG

Not Yet Recruiting

168

Research Site

Manchester, United Kingdom, M20 4BX

Not Yet Recruiting

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here